BackVentyx Biosciences Overview

Ventyx Biosciences Accounts Payable

Track Ventyx Biosciences's accounts payable ($990K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$993000.00
56.56% YoYΔ $-1.29M vs prior year quarter

Peer trimmed avg / median

Loading

Ventyx Biosciences Accounts Payable History

Loading

Ventyx Biosciences vs. peers: Accounts Payable Comparison

Loading

Ventyx Biosciences Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ventyx Biosciences (VTYX) FAQ

Ventyx Biosciences posts a accounts payable of $990K as of September 2025. That compares with $2.3M in the prior-year period — down 56.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Ventyx Biosciences's accounts payable was $2.3M. The latest reading is $990K — a 56.6% year-over-year decrease (period ending September 2025). Use the history and growth charts on this page for a longer lookback.

Accounts Payable is one piece of Ventyx Biosciences's financial statement story. At $990K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for VTYX's accounts payable usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Ventyx Biosciences's other metric pages and overview cover the third.